Probiotics May Reduce Chemotherapy Side Effects in Breast Cancer Patients
Emerging research suggests that multi-strain probiotics may help reduce common chemotherapy side effects such as fatigue and nausea in breast cancer patients, improving quality of life during treatment.
Chemotherapy remains a cornerstone in breast cancer treatment, renowned for its effectiveness in combating cancer cells. However, it also comes with significant side effects, including fatigue, weakness, and heightened vulnerability to infections, which can impact patients' quality of life and treatment adherence. Recent research highlights the potential role of probiotics as a supportive supplement during chemotherapy.
A study published in the open-access journal Pharmacia investigated the impact of multi-strain probiotics on chemotherapy-related side effects in breast cancer patients. The study tracked improvements in symptoms such as fatigue and nausea, showing that probiotic supplementation—comprising seven different bacterial strains—could alleviate these common adverse effects both before and after treatment.
In addition to symptom relief, the research found that probiotics helped improve blood urea nitrogen levels, which are linked to kidney function and overall metabolic health. Patients also experienced greater independence in their daily activities, likely due to reduced fatigue and nausea. These findings suggest that certain probiotic strains may support immune function and overall well-being during intensive cancer therapies.
Despite promising results, researchers emphasize the need for larger-scale studies to confirm these benefits and determine the most effective probiotic formulations. Incorporating probiotics into standard cancer care could, in the future, offer a safe and accessible way to mitigate side effects and enhance patient quality of life during chemotherapy.
Source: https://medicalxpress.com/news/2025-05-probiotic-supplementation-chemotherapy-side-effects.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
FDA Approves Innovative Eye Implant to Combat Vision Loss in Rare Retina Disease
The FDA has approved ENCELTO, a groundbreaking eye implant that slows vision loss in patients with macular telangiectasia type 2, offering hope through advanced neuroprotective therapy.
Decline in Preventive Heart Screenings Among Disabled Adults During the Pandemic
A new study reveals that preventive heart screenings for adults with disabilities declined sharply during the COVID-19 pandemic, worsening existing healthcare disparities. Learn about the implications and needed improvements in care access.
Accreditation Program Significantly Enhances Surgical Quality in Hospitals, Study Finds
A comprehensive study shows that accreditation programs by the American College of Surgeons significantly improve surgical quality across U.S. hospitals, fostering continuous patient safety and care enhancements.
Breakthrough in Cancer Precision Therapy: Identifying Patients Who Benefit from Bexmarilimab
A new study unveils how bexmarilimab activates the immune system against cancer and introduces a gene signature for selective patient treatment, advancing personalized immunotherapy.